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Sir,
b-Lactam antibiotics are extensively used in human and veterin-
ary medicine. The detection rate of extended-spectrum
b-lactamase (ESBL)-producing Enterobacteriaceae isolated from
humans has increased rapidly worldwide.
1 In addition, ESBLs
have been increasingly described in bacterial populations circu-
lating in animals.
2,3 Recently, a high diversity of ESBLs in
Escherichia coli was reported in Belgian poultry farms. In that
instance, CTX-M enzymes were the predominant ESBL family.
4
CTX-M-2-producing Salmonella enterica serovar Virchow
strains and TEM-52-producing S. enterica serovar Infantis
strains have also been isolated from Belgian poultry.
2,3 This
raises a potential public health concern. Moreover, the presence
of ESBLs in the microbiota of food-producing animals may
pose a human health hazard since these bacteria may represent a
reservoir of resistance genes for pathogens causing disease in
humans and animals.
4 Therefore, to demonstrate whether a
common ESBL gene pool exists among isolates in different
hosts, we characterized the plasmids and determined the location
and transfer possibilities of the ESBLs blaTEM-52, blaCTX-M-2
and blaCTX-M-15 that were present in different members of
Enterobacteriaceae isolated from humans, broilers and pigs.
Fourteen blaTEM-52-, blaCTX-M-2-o rblaCTX-M-15-carrying
clonally unrelated strains were used in this study (Table 1).
These strains were isolated in Belgium from humans, pigs and
broilers. The human E. coli strains were isolated from patients
hospitalized at the Ghent University Hospital. All isolates from
poultry were obtained from the faeces of healthy broilers. The
E. coli and Klebsiella pneumoniae isolates were obtained as
described previously.
4 The S. enterica isolates from poultry were
collected in the framework of mandatory Salmonella monitoring
programmes in Belgium. The two porcine E. coli isolates origi-
nated from pigs with diarrhoea. The ESBL gene of each isolate
was characterized as described previously by isoelectric focus-
ing, PCR and sequencing.
4 Plasmid transfer experiments were
carried out as described previously.
2 The antimicrobial suscepti-
bility of the parental strains and their E. coli transconjugants
was determined by the Kirby–Bauer disc diffusion test
(Neo-Sensitabs, Rosco Diagnostica, Taastrup, Denmark)
(Table 1).
4 For the parental strains and their E. coli transconju-
gants, plasmid proﬁles were determined and the size of each
ESBL-carrying plasmid was estimated.
2 The incompatibility
(Inc) group of each ESBL-carrying plasmid was deﬁned by the
PCR-based replicon typing method.
5 Restriction fragment length
polymorphism (RFLP) ﬁngerprint analysis and Southern blot
hybridization were performed as described previously.
2
In order to better understand the spread and persistence of
mobile b-lactam resistance plasmids among different members
of Enterobacteriaceae isolated from different reservoirs, a closer
look at the pool of conjugative plasmids was appropriate and
timely.
All isolates tested here contained high-molecular-weight
ESBL-carrying plasmids ( 150 kb) and, for all these isolates,
E. coli transconjugants were obtained. The blaCTX-M-2-,
blaTEM-52- and blaCTX-M-15-carrying plasmids belonged to
IncHI2, IncI1 and IncI1, respectively (Table 1), as has already
been demonstrated in previous reports.
2,3,6 RFLP analysis of
plasmid DNA from the transconjugants revealed, in most cases,
closely related ﬁngerprints for plasmids carrying the same
ESBL gene. All blaTEM-52-carrying plasmids showed the same
ﬁngerprint pattern analysis, suggesting that this is a rather
stable plasmid circulating in different members of the
Enterobacteriaceae, present in different animal reservoirs and in
humans. Southern blot hybridization with a blaTEM-52 probe
revealed two PstI fragments of 2.75 and 2.9 kb, as has already
been shown in a previous report.
3 The spread of a
blaCTX-M-2-carrying multiresistant plasmid among E. coli and
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ESBL/parental
strain
a Species Source
Year of
isolation Non-b-lactam resistance (parental strains)
b
Co-transferred
resistance
Transfer
frequency
Replicon
typing
TEM-52
B1-54 E. coli broiler 2007 TET, NAL none 1.27 10
23 I1
B8-6 E. coli broiler 2007 TET, SULPH, TMP, KAN, CHL, STR, NAL none 1.11 10
23 I1
B7-9 K. pneumoniae broiler 2007 TET, KAN, NEO none 1.2 10
23 I1
But 31 E. coli human 2006 none none 1.35 10
23 I1
10101-1 S. enterica serovar Infantis broiler 2004 none none 1.4 10
23 I1
CTX-M-2
B4-25 E. coli broiler 2007 TET, SULPH, TMP, STR TET, SULPH, TMP,
STR
0.89 10
23 HI2
BUT 10 E. coli human 2006 TET, SULPH, TMP, STR TET, SULPH, TMP,
STR
0.99 10
23 HI2
138P E. coli pig 2006 TET, SULPH, TMP, STR TET, SULPH, TMP,
STR
1.1 10
23 HI2
CODA-1 S. enterica serovar Virchow broiler 2004 TET, SULPH, TMP, STR, NAL TET, SULPH, TMP,
STR
0.8 10
23 HI2
142-1 S. enterica serovar Virchow broiler 2001 TET, SULPH, TMP, STR, NAL TET, SULPH, TMP,
STR
0.76 10
23 HI2
CTX-M-15
B4-75 E. coli broiler 2007 none none 6.9 10
23 I1
BUT 11 E. coli human 2006 TET, SULPH, TMP, STR NAL, ENR, NEO,
KAN, GEN
none 5.4 10
23 I1
135P E. coli pig 2006 SULPH, TMP, ENR, NEO, GEN, FFC, NAL none 6.3 10
23 I1
CODA-2 S. enterica serovar
Typhimurium
broiler 2007 none none 5.7 10
23 I1
aAll strains were isolated from faeces, with the exception of BUT 10 that was isolated from the human throat. The RFLP ﬁngerprint pattern of the ESBL-carrying plasmid of the 10101-1 isolate and the
142-1 isolate have been described previously
2,3 and were taken into account for RFLP ﬁngerprint analysis to compare with the ESBL-carrying plasmids of the isolates used in this study.
bAntimicrobial drugs used were the following: chloramphenicol (CHL), enroﬂoxacin (ENR), ﬂorfenicol (FFC), gentamicin (GEN), kanamycin (KAN), nalidixic acid (NAL), neomycin (NEO), tetracycline
(TET), trimethoprim (TMP), streptomycin (STR), sulphonamides (SULPH).
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7S. enterica isolates from pigs and broilers was demonstrated.
Only the plasmid from the human E. coli isolate differed in
RFLP ﬁngerprint pattern from the other blaCTX-M-2-carrying
plasmids. Southern blot hybridization with a blaCTX-M-2 probe
revealed a .10 kb EcoRI fragment in the plasmids from the
porcine and broiler E. coli isolates and from the Salmonella
Virchow CODA-1 isolate. Two EcoRI fragments of 6 and 10 kb
were found in the plasmid from the human E. coli isolate and in
the plasmid from the Salmonella Virchow 142-1 isolate.
2 For
the blaCTX-M-15-carrying plasmids, results of RFLP analysis
were identical except for the plasmid from the human E. coli
strain. For the animal strains, Southern blot hybridization with a
blaCTX-M-15 probe revealed two EcoRI fragments of 6.5 and 7 kb
and one 5 kb PstI fragment. The plasmid from the human E.
coli strain showed 5 and .10 kb EcoRI fragments and a 5.5 kb
PstI fragment. The Southern blot results suggest the existence of
two copies of the tested ESBLs on their  150 kb plasmids.
The differences seen in the RFLP analyses for the
blaCTX-M-2-a n dblaCTX-M-15-carrying plasmids may possibly
reﬂect the rapid evolution of these plasmids as they were
exposed to different environmental stresses. The human, porcine
and poultry environments may be experienced by bacteria in
different ways.
In summary, ESBL resistance plasmids appear to move
readily between different microorganisms and different ecosys-
tems. TEM-52-carrying cephalosporin-resistant organisms may
have been transmitted from food animals to humans, or vice
versa.
3
For the CTX-M-2- or CTX-M-15-carrying cephalosporin-
resistant organisms, exchange between food animals and
humans, however, remains unclear, mainly due to the unknown
plasticity and evolutionary speed of the plasmids carrying them.
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Sir,
Bartonella species are Gram-negative bacilli that belong to the
alpha 2 subgroup of Proteobacteria. Due to the fastidious nature
of these bacteria and the limited number of available isolates
worldwide, there are few data on in vitro susceptibility to anti-
biotics. There are anecdotal reports of the use of ﬂuoroquino-
lones in the treatment of infections due to Bartonella henselae
or Bartonella quintana.
1 However, failures or relapses have been
observed with these compounds suggesting that antibiotic resist-
ance may develop during treatment.
1,2 Thus, deciphering the
molecular mechanism of resistance for these bacteria remains
important since in vivo data do not correlate well with in vitro
ﬁndings. Bacterial resistance to ﬂuoroquinolones can essentially
develop through two main mechanisms, namely a decrease in
the intra-bacterial concentration of the drug, or alterations in the
drug’s target enzymes.
3 Target site alteration results from
mutations in the chromosomal genes encoding the quinolone
resistance-determining region (QRDR) of DNA gyrase and
topoisomerase IV.
3 We have recently reported that
ﬂuoroquinolone-resistant mutants can be easily obtained in vitro
for Bartonella bacilliformis suggesting that these antibiotics
should not be used to treat infectious due to this bacterium, i.e.
Carrion’s disease.
4 Moreover, we have demonstrated that an
intrinsic mutation in the QRDR region of DNA gyrase confers
heterogeneity of susceptibility to ﬂuoroquinolones and a low
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